Abstract:Background Adenine base editors (ABEs) are promising therapeutic gene editing tools that can efficiently convert targeted A•T to G•C base pairs in the genome. However, the large size of commonly used ABEs based on SpCas9 hinders its delivery in vivo using certain vectors such as adeno-associated virus (AAV) during preclinical applications. Despite a number of approaches having previously been attempted to overcome that challenge, including split Cas9-derived and numerous domain-deleted versions of editors, whether base editor (BE) and prime editor (PE) systems can also allow deletion of those domains remains to be proven. In this study, we present a new small ABE (sABE) with significantly reduced size. Results We discovered that ABE8e can tolerate large single deletions in the REC2 (Δ174-296) and HNH (Δ786-855) domains of SpCas9, and these deletions can be stacked together to create a new sABE. The sABE showed higher precision than the original ABE8e, with proximally shifted protospacer adjacent motif (PAM) editing windows (A3- A15), and comparable editing efficiencies to 8e-SaCas9-KKH. The sABE system efficiently generated A-G mutations at disease-relevant loci (T1214C in GAA and A494G in MFN2 ) in HEK293T cells and several canonical Pcsk9 splice sites in N2a cells. Moreover, the sABE enabled in vivo delivery in a single adeno-associated virus (AAV) vector with slight efficiency. Furthermore, we also successfully edited the genome of mouse embryos by microinjecting mRNA and sgRNA of sABE system into zygotes. Conclusions We have developed a substantially smaller sABE system that expands the targeting scope and offers higher precision of genome editing. Our findings suggest that the sABE system holds great therapeutic potential in preclinical applications.

Efficient DNA base editing via an optimized DYW-like deaminase

Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Accelerated discovery and miniaturization of novel single-stranded cytidine deaminases

Efficient C-to-G Base Editing with Improved Target Compatibility Using Engineered Deaminase-nCas9 Fusions.

Increasing the Efficiency and Targeting Range of Cytidine Base Editors Through Fusion of a Single-Stranded DNA-binding Protein Domain

Engineering APOBEC3A deaminase for highly accurate and efficient base editing

Glycosylase-based Base Editors for Efficient T-to-G and C-to-G Editing in Mammalian Cells

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences

Eliminating Base-Editor-induced Genome-Wide and Transcriptome-Wide Off-Target Mutations

Engineering of cytosine base editors with DNA damage minimization and editing scope diversification

Efficient and High-Fidelity Base Editor with Expanded PAM Compatibility for Cytidine Dinucleotide

Direct delivery of stabilized Cas-embedded base editors achieves efficient and accurate editing of clinically relevant targets

A New Compact Adenine Base Editor Generated Through Deletion of HNH and REC2 Domain of SpCas9

Efficient CRISPR-Cas9 based cytosine base editors for phytopathogenic bacteria

Compact zinc finger architecture utilizing toxin-derived cytidine deaminases for highly efficient base editing in human cells

Highly Efficient Base Editing in Staphylococcus Aureus Using an Engineered CRISPR RNA-guided Cytidine Deaminase.

Expanding the Genome-Targeting Scope and the Site Selectivity of High-Precision Base Editors

An APOBEC3A-Cas9 Base Editor with Minimized Bystander and Off-Target Activities

CRISPR/Cas9-deaminase Enables Robust Base Editing in Rhodobacter Sphaeroides 2.4.1

Base editing in Streptomyces with Cas9 deaminase fusions